Instituto Dante Pazzanese de Cardiologia-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2021

  1. Impact of Endothelial Shear Stress on Absorption Process of Resorbable Magnesium Scaffold: A BIOSOLVE-II Substudy

    Cardiovascular Revascularization Medicine, Vol. 29, pp. 9-15

2019

  1. First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study

    Cardiovascular Revascularization Medicine, Vol. 20, Núm. 5, pp. 392-398

2015

  1. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis

    Circulation, Vol. 131, Núm. 2, pp. 131-140

  2. Candida infective endocarditis: An observational cohort study with a focus on therapy

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 4, pp. 2365-2373

  3. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study

    Clinical Infectious Diseases, Vol. 60, Núm. 5, pp. 741-749

  4. One-year outcome following biological or mechanical valve replacement for infective endocarditis

    International Journal of Cardiology, Vol. 178, pp. 117-123

2014

  1. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: Results from the FREEDOM trial

    Journal of the American College of Cardiology, Vol. 64, Núm. 12, pp. 1189-1197

2013

  1. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort

    PLoS ONE, Vol. 8, Núm. 5

  2. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke

    Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 209-217

2010

  1. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial

    The Lancet, Vol. 376, Núm. 9748, pp. 1233-1243

  2. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 29, Núm. 10, pp. 1203-1210

2009

  1. The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes

    American Heart Journal, Vol. 158, Núm. 2, pp. 201.e5

2007

  1. Anatomical and physiologic assessments in patients with small coronary artery disease: Final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial

    American Heart Journal, Vol. 153, Núm. 2, pp. 296.e1-296.e7

  2. Non-HACEK gram-negative bacillus endocarditis

    Annals of Internal Medicine, Vol. 147, Núm. 12, pp. 829-835

2002

  1. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial

    Journal of the American Medical Association, Vol. 287, Núm. 24, pp. 3215-3222

1998

  1. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

    Lancet, Vol. 352, Núm. 9129, pp. 673-681